Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt

about

THRIVE score predicts clinical and radiological outcome after endovascular therapy or thrombolysis in patients with anterior circulation stroke in everyday clinical practice.

P2860

Q38757416-6A3A0763-D834-47D9-AB8E-59A54DAB1796

P2860

Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt

Item

http://www.wikidata.org/entity/Q36657709

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Investigating the utility of p ...... ke patients in the stroke belt

@ast

Investigating the utility of p ...... ke patients in the stroke belt

@en

type

Item

label

Investigating the utility of p ...... ke patients in the stroke belt

@ast

Investigating the utility of p ...... ke patients in the stroke belt

@en

prefLabel

Investigating the utility of p ...... ke patients in the stroke belt

@ast

Investigating the utility of p ...... ke patients in the stroke belt

@en

P1476

Investigating the utility of p ...... ke patients in the stroke belt

@en

P2093

Amelia K Boehme

http://www.w3.org/2001/XMLSchema#string

Andrei V Alexandrov

http://www.w3.org/2001/XMLSchema#string

Anne W Alexandrov

http://www.w3.org/2001/XMLSchema#string

April Sisson

http://www.w3.org/2001/XMLSchema#string

J Thomas Houston

http://www.w3.org/2001/XMLSchema#string

Luis Cava

http://www.w3.org/2001/XMLSchema#string

Mark R Harrigan

http://www.w3.org/2001/XMLSchema#string

Michael J Lyerly

http://www.w3.org/2001/XMLSchema#string

Mohammad Alvi

http://www.w3.org/2001/XMLSchema#string

Niren Kapoor

http://www.w3.org/2001/XMLSchema#string

P2860

Stroke Declines From Third to Fourth Leading Cause of Death in the United States: Historical Perspective and Challenges Ahead

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.

Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke

Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke

Adjusting for multiple testing--when and how?

Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score.

Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

P304

2001-2006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSTROKECEREBROVASDIS.2014.02.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karen C Albright

P577

2014-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264624522

http://www.w3.org/2001/XMLSchema#string

P698

25113079

http://www.w3.org/2001/XMLSchema#string

P932

4780244

http://www.w3.org/2001/XMLSchema#string

Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt

about

P2860

P2860

Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932